Rapcabtagene autoleucel Clinical Trials
3 recruitingBiologic
Phase 23Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease
Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)
Novartis Pharmaceuticals27 enrolled12 locationsNCT07048197
Recruiting
Phase 2
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals123 enrolled67 locationsNCT06665256
Recruiting
Phase 2
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
ANCA Associated Vasculitis (AAV)
Novartis Pharmaceuticals126 enrolled35 locationsNCT06868290